Fig. 2From: Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunitiesIntegrin activation. Simplified binding interactions between integrin α/β subunit, extracellular ligand, FAK, Src and their activation components such as CAS, paxillin and talinBack to article page